Table 1.
Antidepressants included in the study.
Table 2.
Basic characteristics for women exposed to an antidepressant during pregnancy.
Figure 1.
Point prevalence of pregnant women in treatment with an antidepressant based on estimated treatment periods.
SSRI, selective serotonin reuptake inhibitor; TCA, tricyclic antidepressants; AD, antidepressant.
Figure 2.
Percentage of pregnant women in treatment with an antidepressant for each day from 180 days before conception to 630 days after conception (approximately 1 year after mean time of delivery).
The figure is divided into three areas of different color indicating the period of treatment start; before (dark blue), during (blue) or after pregnancy (light blue).
Table 3.
Number of women exposed to an antidepressant during pregnancy.
Table 4.
Pre-pregnancy treatment-naïve women exposed to an antidepressant.
Figure 3.
Percentage of pregnant women in treatment with an SSRI for each day from 180 days before conception to 630 days after conception (approximately 1 year after mean time of delivery).
Lines depict the different types of SSRIs.